Table 3 Characteristics of psychotropic drugs at the start of the study
From: Psychotropic drug use among people with dementia – a six-month follow-up study
Drug | n (%) | Dose, mean (mg) ± SD | Range (mg) | Dose, median (mg) |
|---|---|---|---|---|
Antidepressants (N06A) | ||||
Citalopram | 84 (52.5) | 19.6 ± 6.1 | 10-40 | 20.0 |
Clomipramine | 1 (0.6) | 175.0 | 175.0 | |
Escitalopram | 1 (0.6) | 10.0 | 10.0 | |
Sertraline | 32 (20.0) | 68.0 ± 31.3 | 25-150 | 50.0 |
Mianserine | 8 (5.0) | 27.5 ± 10.3 | 10-40 | 30.0 |
Mirtazapine | 26 (16.3) | 30.6 ± 7.9 | 15-60 | 30.0 |
Venlafaxine | 8 (5.0) | 112.5 ± 56.7 | 75-225 | 75.0 |
Anxiolytics (N05B) | ||||
Hydroxyzine | 7 (15.9) | 32.9 ± 22.1 | 10-75 | 25.0 |
Diazepam | 1 (2.3) | 3.3 | 3.3 | |
Oxazepam | 31 (70.5) | 24.0 ± 26.8 | 5-135 | 15.0 |
Alprazolam | 4 (9.0) | 2.6 ± 2.5 | 0.5-6 | 2.0 |
Buspirone | 1 (2.3) | 15.0 | 15.0 | |
Hypnotics and sedatives (N05C) | ||||
Clometiazol | 35 (26.3) | 651.4 ± 273.7 | 300-1500 | 600.0 |
Flunitrazepam | 15 (11.3) | 0.7 ± 0.3 | 0.5-1 | 0.5 |
Propiomazine | 37 (27.8) | 33.4 ± 12.5 | 12-50 | 25.0 |
Zolpidem | 19 (14.3) | 6.4 ± 2.5 | 2.5-10 | 5.0 |
Zopiclone | 27 (20.3) | 6.9 ± 2.2 | 5-15 | 7.5 |